BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//g6pd Deficiency Foundation - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://g6pddf.org
X-WR-CALDESC:Events for g6pd Deficiency Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230519T120000
DTEND;TZID=America/New_York:20230519T130000
DTSTAMP:20260513T191352
CREATED:20230517T130102Z
LAST-MODIFIED:20230517T130610Z
UID:2339-1684497600-1684501200@g6pddf.org
SUMMARY:NBSTRN 2023 Network Meeting
DESCRIPTION:2023 NBSTRN Network Meeting: Celebrating Advocacy and Research on the 60th Anniversary of Newborn Screening\nIn 2023\, the newborn screening (NBS) community of researchers\, healthcare professionals\, parents\, families\, advocates\, and state newborn screening programs are celebrating the 60th anniversary of NBS. On May 18-19\, 2023\, the Newborn Screening Translational Research Network (NBSTRN) is marking this significant milestone with a two-day virtual meeting that will showcase the important role of advocacy and research in NBS. In 1963 Dr. Robert Guthrie’s discovery of a biomarker for phenylketonuria (PKU) that could be detected in a newborn’s blood ignited six decades of ground-breaking investigations by researchers have delivered new screening\, diagnostic technologies and therapies that have expanded NBS to over 80 conditions. Advocacy from parents\, families\, and communities have collectively accelerated this expansion of NBS and continues to highlight important areas where the NBS community can work to ensure the timely diagnosis\, treatment\, and lifelong management of newborns identified with a condition through NBS. \n2023 also marks the 15th year of ACMG leading the NBSTRN. Since 2008 the NBSTRN has facilitated ground-breaking research in NBS and facilitated the expansion of NBS and the translation of research into clinical practice and public health. The NBSTRN team at ACMG has a mission to facilitate the discovery and validation of novel technologies to screen and diagnose disease\, pilot new technologies and treatments\, describe the ethical\, legal\, and social implications of NBS research\, and collect longitudinal health and genomic data. By joining the NBSTRN network\, the ACMG community can help build new connections and strengthen partnerships across government\, academia\, clinical care\, public health\, and industry; support collection\, analysis\, storage\, and sharing of phenotypic and genomic data; guide newborn screening research studies and pilot studies; and support the validation of new technologies and treatments for newborn screening.\n			\n				REGISTER NOW!
URL:https://g6pddf.org/event/nbstrn-2023-network-meeting/
CATEGORIES:Network
ATTACH;FMTTYPE=image/jpeg:https://g6pddf.org/wp-content/uploads/2023/05/NBSTRN-2023-Network-Meeting.jpg
END:VEVENT
END:VCALENDAR